Cargando…

Levels of anti-CMV antibodies are modulated by the frequency and intensity of virus reactivations in kidney transplant patients

Anti-CMV (cytomegalovirus) antibody titers are related to immune alterations and increased risk of mortality. To test whether they represent a marker of infection history, we analyzed the effect of viral reactivations on the production of specific antibodies in kidney transplant patients. We quantif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iglesias-Escudero, María, Moro-García, Marco Antonio, Marcos-Fernández, Raquel, García-Torre, Alejandra, Álvarez-Argüelles, Marta Elena, Suárez-Fernández, María Luisa, Martínez-Camblor, Pablo, Rodríguez, Minerva, Alonso-Arias, Rebeca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895001/ https://www.ncbi.nlm.nih.gov/pubmed/29641536 http://dx.doi.org/10.1371/journal.pone.0194789

Ejemplares similares

CMV Infection Is Directly Related to the Inflammatory Status in Chronic Heart Failure Patients
por: García-Torre, Alejandra, et al.
Publicado: (2021)

Acquisition of New Migratory Properties by Highly Differentiated CD4+CD28(null) T Lymphocytes in Rheumatoid Arthritis Disease
por: Rioseras, Beatriz, et al.
Publicado: (2021)

Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors
por: Pita-Lopez, María Luisa, et al.
Publicado: (2009)

Cytomegalovirus in Haematological Tumours
por: Alonso-Álvarez, Sara, et al.
Publicado: (2021)

604 Risk Factors for Cytomegalovirus (CMV) Reactivation in CMV-seropositive Liver Transplant Patients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

CMV Serostatus of Donor-Recipient Pairs Influences the Risk of CMV Infection/Reactivation in HSCT Patients
por: Jaskula, Emilia, et al.
Publicado: (2012)

IgA Vasculitis Complicated by Both CMV Reactivation and Tuberculosis
por: Mizerska-Wasiak, Małgorzata, et al.
Publicado: (2021)

Guillain-Barré Syndrome due to CMV Reactivation after Cardiac Transplantation
por: Steger, Christina Maria, et al.
Publicado: (2012)

Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms
por: Vallejo, Miren, et al.
Publicado: (2022)

IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipients
por: Sadeghi, Mahmoud, et al.
Publicado: (2016)

Donor CMV Reactivation as a Novel Risk Factor for CMV Replication in Seropositive Liver Transplant Recipients
por: Limaye, Ajit P., et al.
Publicado: (2020)

CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality
por: Eberhardt, Kirsten Alexandra, et al.
Publicado: (2023)

926. Risk factors for post-letermovir cytomegalovirus (CMV) reactivation in allogeneic hematopoietic stem cell transplant (HSCT) recipients
por: Mendoza, Maria Alejandra, et al.
Publicado: (2023)

13. CMV Reactivation in refractory ANCA-associated vasculitis
por: Hassan, Neelam, et al.
Publicado: (2019)

Editorial: Immunity to Cytomegalovirus Infections: Challenges and Therapeutic Opportunities
por: Alonso-Arias, Rebeca, et al.
Publicado: (2022)

Cytomegalovirus (CMV)-Specific Perforin and Granzyme B ELISPOT Assays Detect Reactivation of CMV Infection in Inflammatory Bowel Disease
por: Nowacki, Tobias M., et al.
Publicado: (2012)

Successful Use of Heterologous CMV-Reactive T Lymphocyte to Treat Severe Refractory Cytomegalovirus (CMV) Infection in a Liver Transplanted Patient: Correlation of the Host Antiviral Immune Reconstitution with CMV Viral Load and CMV miRNome
por: Miele, Monica, et al.
Publicado: (2021)

Reinfection, reactivation or delayed complication of the initial SARS-CoV-2 infection()
por: González-Iglesias, Ignacio, et al.
Publicado: (2021)

Tissue-specific control of latent CMV reactivation by regulatory T cells
por: Almanan, Maha, et al.
Publicado: (2017)

CMV reactivation caused by methylprednisolone therapy for ARDS after esophagectomy
por: Sato, Yusuke, et al.
Publicado: (2012)

When Aging Reaches CD4+ T-Cells: Phenotypic and Functional Changes
por: Moro-García, Marco Antonio, et al.
Publicado: (2013)

Molecular Mechanisms Involved in the Aging of the T-cell Immune Response
por: Moro-García, Marco Antonio, et al.
Publicado: (2012)

CMV hyperimmune globulin as salvage therapy for recurrent or refractory CMV infection in children undergoing hematopoietic stem cell transplantation
por: Panesso, Melissa, et al.
Publicado: (2023)

Lack of cytomegalovirus (CMV)-specific cell-mediated immune response using QuantiFERON-CMV assay in CMV-seropositive healthy volunteers: fact not artifact
por: Valle-Arroyo, Jorge, et al.
Publicado: (2020)

Immunomagnetic Capture of Faecalibacterium prausnitzii Selectively Modifies the Fecal Microbiota and Its Immunomodulatory Profile
por: Marcos-Fernández, Raquel, et al.
Publicado: (2023)

Effect of Cytomegalovirus (CMV) and Ageing on T-Bet and Eomes Expression on T-Cell Subsets
por: Hassouneh, Fakhri, et al.
Publicado: (2017)

Skull Vibration-Induced Nystagmus and High Frequency Ocular Vestibular-Evoked Myogenic Potentials in Superior Canal Dehiscence
por: Batuecas-Caletrío, Ángel, et al.
Publicado: (2022)

CMV Latent Infection Improves CD8+ T Response to SEB Due to Expansion of Polyfunctional CD57+ Cells in Young Individuals
por: Pera, Alejandra, et al.
Publicado: (2014)

Exantema postvacunal en paciente con enfermedad relacionada con IgG4
por: Fernández-Prada, María, et al.
Publicado: (2018)

How Do Donor-Recipient CMV Serostatus and Post-Hematopoietic Stem Cell Transplantation CMV Reactivation Affect Outcomes in Acute Leukemia Patients?
por: Vaezi, Mohammad, et al.
Publicado: (2017)

491. Characterizing the Association of Pre-Existing Cytomegalovirus (CMV)-specific Humoral Immunity with CMV Reactivation Risk after Hematopoietic Cell Transplantation (HCT)
por: Zamora, Danniel, et al.
Publicado: (2022)

S291: LONG-TERM SAFETY AND EFFICACY OF CMV/EBV-SPECIFIC T CELLS FOR CMV AND EBV CO-REACTIVATION AFTER HAPLOIDENTICAL STEM CELL TRANSPLANTATION
por: Xuying, Pei, et al.
Publicado: (2023)

Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients
por: McBride, Jacqueline M, et al.
Publicado: (2019)

Effect of Type of Dialysis on CMV-Specific CD8+ T Cells in Kidney Transplant Candidates
por: Vidal-Castiñeira, Jose Ramón, et al.
Publicado: (2019)

Impact of CMV reactivation on relapse of acute myeloid leukemia after HCT is dependent on disease stage and ATG
por: Turki, Amin T., et al.
Publicado: (2021)

The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMV
por: Carbone, Javier
Publicado: (2016)

CMV reactivation initiates long-term expansion and differentiation of the NK cell repertoire
por: Hassan, Norfarazieda, et al.
Publicado: (2022)

Influence of Inflammation in the Process of T Lymphocyte Differentiation: Proliferative, Metabolic, and Oxidative Changes
por: Moro-García, Marco A., et al.
Publicado: (2018)

CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients
por: Schulz, Uwe, et al.
Publicado: (2016)

Predictors of CMV Infection in CMV-Seropositive Kidney Transplant Recipients: Impact of Pretransplant CMV-Specific Humoral Immunity
por: Kirisri, Similan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rc2428b9ajttbfeh1vg39fq7pm